Overview of outcome parameters of the Prospective Follow-up, Marathon, Long-Term, Inflammation, Cardiovascular System study
| Examinations | Outcome parameters |
| Anthropometry | Height, weight, body fat percentage, BMI, blood pressure and RPP |
| Blood samples | Calcium, potassium, sodium, magnesium iron, glucose, HDL, LDL, cholesterol, triglycerides, IL-6, cardiac troponin, NT-proBNP |
| Resting and exercise ECG | Resting and exercise heart rate, PR interval, QRS duration, QT interval, QTc interval, ST-segment alterations, T-wave inversion, early repolarisation pattern |
| Echocardiography | Root and ascending aortic diameters, LVEDD, IVSd, LVPWd, LVESD, IVSs, LVPWs, LVEF, LAVI, HVDickhut, markers of diastolic function (E/A, E/e’ septal und lateral), valve regurgitations, RVEF, TAPSE, strain analytics |
| Carotid sonography | Plaques, IMT |
| Retinal vessel analysis | CRAE, CRVE and AVR |
| Cardiopulmonary exercise testing | Maximal workload (W/kg), VO2peak, VT1, VT2 lactate, blood pressure, Borg Scale 6–20 |
| Questionnaire | Prevalence of diseases and sports history |
BMI, body mass index; HDL, high-density lipoprotein; HV, heart volume; IL, interleukin; IMT, intima–media thickness; IVSd, interventricular septum thickness at end diastole; IVSs, interventricular septum thickness at end systole; LAVI, left atrial volume index; LDL, low-density lipoprotein; LV, Left ventricle; LVEDD, left ventricular end diastolic diameter; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic diameter; LVPWd, left ventricular posterior wall thickness at end diastole; LVPWs, left ventricular posterior wall thickness at end systole; NT-proBNP, N-terminal pro-B-type natriuretic peptide; RPP, rate pressure product; RVEF, right ventricular ejection fraction; TAPSE, tricuspid annular plane systolic excursion.